Earnings per Share (Note)

9 Months Ended

Sep. 30, 2025

The following table sets forth the computation of basic and diluted (loss) earnings per share for the three and nine months ended September 30, 2025 and 2024:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2025		2024		2025		2024
Numerator:
Net (loss) income - basic	$	(4,247)	$	235	$	(9,692)	$	(18,508)
Adjustment for (income)/expense related to the 2027 convertible notes exchanged (1)	—		—		(2,626)		—
Net (loss) income - diluted	$	(4,247)	$	235	$	(12,318)	$	(18,508)
Denominator:
Weighted average shares - basic	48,195		47,231		47,920		47,038
Dilutive effect of potential common shares	—		107		—		—
Dilutive effect of 2027 convertible notes exchanged	—		—		2,668		—
Weighted average shares - diluted	48,195		47,338		50,588		47,038
Basic (loss) earnings per share	$	(0.09)	$	—	$	(0.20)	$	(0.39)
Diluted (loss) earnings per share	$	(0.09)	$	—	$	(0.24)	$	(0.39)

(1) (Income)/expense related to the 2027 convertible notes exchanged includes gain on debt extinguishment, coupon interest expense, amortization of debt premium, and amortization of debt issuance costs, net of associated income tax effect.

Dilutive potential common shares consist of shares issuable upon the vesting of restricted stock units ("RSUs") and market stock units ("MSUs"). Potential common shares determined to be antidilutive and excluded from diluted weighted average shares were 3.5 million and 2.5 million for the three months ended September 30, 2025 and 2024, respectively, and 2.9 million and 1.9 million for the nine months ended September 30, 2025 and 2024, respectively. In addition, potential common

shares related to the outstanding convertible notes determined to be antidilutive and excluded from diluted weighted average shares were 13.4 million and 6.4 million for the three months ended September 30, 2025 and 2024, respectively, and 6.0 million and 6.5 million for the nine months ended September 30, 2025 and 2024, respectively.